|
SSFA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72495351336011E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78645986892434E-12 |
| Normal-vs-Stage2 |
1.067040E-01 |
| Normal-vs-Stage3 |
1.156750E-03 |
| Normal-vs-Stage4 |
1.184040E-04 |
| Stage1-vs-Stage2 |
4.635600E-02 |
| Stage1-vs-Stage3 |
5.082200E-01 |
| Stage1-vs-Stage4 |
5.109400E-01 |
| Stage2-vs-Stage3 |
3.115200E-01 |
| Stage2-vs-Stage4 |
4.801400E-01 |
| Stage3-vs-Stage4 |
8.647000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76514358685154E-12 |
| Normal-vs-AfricanAmerican |
7.72170000162831E-08 |
| Normal-vs-Asian |
2.94059999994545E-06 |
| Caucasian-vs-AfricanAmerican |
6.622400E-01 |
| Caucasian-vs-Asian |
5.721200E-01 |
| AfricanAmerican-vs-Asian |
4.482000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.55351295663786E-15 |
| Normal-vs-Female |
2.238300E-04 |
| Male-vs-Female |
4.339600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.61860000000136E-05 |
| Normal-vs-Extreme_Weight |
1.64179780881568E-12 |
| Normal-vs-Obese |
6.54399999744371E-08 |
| Normal-vs-Extreme_Obese |
1.065840E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.746600E-01 |
| Normal_Weight-vs-Obese |
9.858000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.713600E-01 |
| Extreme_Weight-vs-Obese |
1.611640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.772800E-01 |
| Obese-vs-Extreme_Obese |
8.569400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.562100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.30269994791377E-09 |
| Normal-vs-Age(61-80Yrs) |
5.45119505090952E-14 |
| Normal-vs-Age(81-100Yrs) |
1.014250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.455800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.818000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.380200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.668500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.212600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.640800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.44759784556936E-11 |
| Normal-VS-Type2 PRCC |
2.0940005285297E-10 |
| Normal-VS-KIRP CIMP |
6.916400E-01 |
| Normal-VS-Unclassified PRCC |
6.22230000000279E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.527830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.748300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.490400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.375930E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.772600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.701600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.17250037141071E-10 |
| Normal-vs-N1 |
4.614400E-02 |
| Normal-vs-N2 |
1.992390E-04 |
| N0-vs-N1 |
2.075200E-01 |
| N0-vs-N2 |
8.934400E-01 |
| N1-vs-N2 |
6.374400E-01 |
|
|
